As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/22/24  Athira Pharma, Inc.               8-K:2,5,7,9 2/21/24   10:807K                                   Donnelley … Solutions/FA 
  1/8/24  Athira Pharma, Inc.               8-K:2,5,9    1/4/24   10:471K                                   Donnelley … Solutions/FA 
 5/22/23  Athira Pharma, Inc.               8-K:5,8,9   5/18/23   14:529K                                   Donnelley … Solutions/FA 
 3/21/22  Athira Pharma, Inc.               8-K:5,9     3/18/22   11:179K                                   Donnelley … Solutions/FA 
 1/31/22  Athira Pharma, Inc.               8-K:5,8,9   1/27/22   13:298K                                   Donnelley … Solutions/FA 
10/21/21  Athira Pharma, Inc.               8-K:5,8,9  10/18/21   12:309K                                   Donnelley … Solutions/FA 
 6/21/21‡ Athira Pharma, Inc.               8-K:5,9     6/16/21   11:188K                                   Donnelley … Solutions/FA 
  3/8/21  Athira Pharma, Inc.               8-K:5,9      3/4/21    2:71K                                    ActiveDisclosure/FA      
 1/11/21  Athira Pharma, Inc.               8-K:5,7,9    1/8/21    2:1.7M                                   ActiveDisclosure/FA      
12/14/20  Athira Pharma, Inc.               8-K:5,9    12/11/20    2:58K                                    ActiveDisclosure/FA      

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Type:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.